TRACON Pharmaceuticals, Inc. (TCON)
Largest Insider Buys in Sector
TCON Stock Price History Chart
TCON Stock Performance
About TRACON Pharmaceuticals, Inc.
TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer in the United States. Its clinical stage products include envafolimab (KN035), a PD-L1 single-domain antibody for the treatment of soft tissue sarcoma; and YH001, an investigational humanized CTLA-4 IgG1 monoclonal antibody for the treatment of various cancer indications. The company's clinical stage products also include TRC102, a small molecule that is in Phase II clinical trial for the treatment of mesothelioma, and in Phase I clinical trial to treat solid tumors and lymphomas, lung cancer, and glioblastoma; and TJ004309, a CD73 antibody that is in Phase I clinical development for the treatment of solid tumors. It has collaboration and license agreements with 3D Medicines Co., Ltd. and Jiangsu Alphamab Biopharmaceuticals Co., Ltd. for the development of envafolimab; I-Mab Biopharma for the development of CD73 antibody TJ004309; Case Western Reserve University for the development of TRC102; and cooperative research and development agreement with National Cancer Institute. The company was formerly known as Lexington Pharmaceuticals, Inc. and changed its name to TRACON Pharmaceuticals, Inc. in March 2005. TRACON Pharmaceuticals, Inc. was incorporated in 2004 and is headquartered in San Diego, California.
Insider Activity of TRACON Pharmaceuticals, Inc.
Over the last 12 months, insiders at TRACON Pharmaceuticals, Inc. have bought $0 and sold $0 worth of TRACON Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at TRACON Pharmaceuticals, Inc. have bought $4.01M and sold $564,873 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 47,000 shares for transaction amount of $35,250 was made by THEUER CHARLES (President and CEO) on 2023‑04‑27.
List of Insider Buy and Sell Transactions, TRACON Pharmaceuticals, Inc.
| 2023-04-27 | THEUER CHARLES | President and CEO | 47,000 0.1999% | $0.75 | $35,250 | -68.63% | ||
| 2023-04-26 | THEUER CHARLES | President and CEO | 3,999 0.0141% | $0.66 | $2,639 | -70.41% | ||
| 2023-03-09 | Opaleye Management Inc. | 10 percent owner | 174,508 0.7697% | $1.38 | $240,821 | -82.03% | ||
| 2023-03-01 | THEUER CHARLES | President and CEO | 4,800 0.0204% | $1.52 | $7,296 | -83.51% | ||
| 2023-02-28 | THEUER CHARLES | President and CEO | 200 0.0008% | $1.52 | $304 | -83.77% | ||
| 2023-01-18 | THEUER CHARLES | President and CEO | 6,800 0.0289% | $1.62 | $11,016 | -81.25% | ||
| 2022-12-29 | Brown Scott B. | Chief Financial Officer | 3,500 0.0156% | $1.49 | $5,215 | -76.86% | ||
| 2022-12-21 | Sale | LARUE WILLIAM R | director | 120 0.0005% | $1.26 | $151 | ||
| 2022-12-14 | Opaleye Management Inc. | director | 167,500 0.7298% | $1.25 | $209,877 | |||
| 2022-12-14 | THEUER CHARLES | President and CEO | 23,000 0.1035% | $1.29 | $29,755 | |||
| 2022-12-06 | Sale | Opaleye Management Inc. | director | 1,539 0.0069% | $1.44 | $2,216 | ||
| 2022-11-18 | THEUER CHARLES | President and CEO | 13,900 0.0626% | $1.41 | $19,599 | |||
| 2022-11-03 | THEUER CHARLES | President and CEO | 9,200 0.0415% | $1.52 | $13,984 | -52.58% | ||
| 2022-11-02 | THEUER CHARLES | President and CEO | 6,000 0.0271% | $1.59 | $9,540 | -54.27% | ||
| 2022-10-18 | Opaleye Management Inc. | director | 12,500 0.0561% | $1.65 | $20,625 | |||
| 2022-10-07 | THEUER CHARLES | President and CEO | 5,000 0.0226% | $1.77 | $8,850 | |||
| 2022-10-03 | THEUER CHARLES | President and CEO | 5,000 0.0223% | $1.67 | $8,350 | |||
| 2022-09-29 | Opaleye Management Inc. | 9,400 0.0438% | $1.74 | $16,370 | -18.68% | |||
| 2022-09-27 | Opaleye Management Inc. | 10 percent owner | 1,700 0.0079% | $1.69 | $2,877 | -15.38% | ||
| 2022-09-22 | Opaleye Management Inc. | 10 percent owner | 17,311 0.0784% | $1.73 | $29,943 | -19.10% |
Insider Historical Profitability
| Opaleye Management Inc. | 10 percent owner | 4324508 13.8854% | $1.45 | 44 | 1 | +21.15% |
| MOTT DAVID M | 10 percent owner | 3466003 11.1289% | $1.45 | 3 | 0 | <0.0001% |
| BARRIS PETER J | 10 percent owner | 3466003 11.1289% | $1.45 | 3 | 0 | <0.0001% |
| BASKETT FOREST | 10 percent owner | 3466003 11.1289% | $1.45 | 3 | 0 | <0.0001% |
| BARRETT M JAMES | 10 percent owner | 3466003 11.1289% | $1.45 | 3 | 0 | <0.0001% |
| SANDELL SCOTT D | 10 percent owner | 3466003 11.1289% | $1.45 | 3 | 0 | <0.0001% |
| KERINS PATRICK J | 10 percent owner | 3466003 11.1289% | $1.45 | 3 | 0 | <0.0001% |
| Sonsini Peter W. | 10 percent owner | 3466003 11.1289% | $1.45 | 3 | 0 | <0.0001% |
| Viswanathan Ravi | 10 percent owner | 3466003 11.1289% | $1.45 | 3 | 0 | <0.0001% |
| Florence Anthony A. Jr. | 10 percent owner | 3466003 11.1289% | $1.45 | 3 | 0 | <0.0001% |
| New Enterprise Associates 14, L.P. | 10 percent owner | 3466003 11.1289% | $1.45 | 3 | 0 | <0.0001% |
| KOLLURI KRISHNA KITTU | 10 percent owner | 2758039 8.8557% | $1.45 | 2 | 0 | <0.0001% |
| Ikarian Capital, LLC | 10 percent owner | 2716840 8.7234% | $1.45 | 8 | 0 | +47.06% |
| DRANT RYAN D | 10 percent owner | 1888474 6.0636% | $1.45 | 1 | 0 | +15.99% |
| Weller Harry R | 10 percent owner | 1888474 6.0636% | $1.45 | 1 | 0 | +15.99% |
| JAFCO Super V3 Investment Limited Partnership | 10 percent owner | 1497053 4.8068% | $1.45 | 1 | 37 | +15.99% |
| THEUER CHARLES | President and CEO | 399417 1.2825% | $1.45 | 44 | 3 | +61.69% |
| Puissance Cross-Border Opportunities V LLC | 10 percent owner | 76048 0.2442% | $1.45 | 1 | 3 | |
| Brown Scott B. | Chief Financial Officer | 21628 0.0694% | $1.45 | 5 | 0 | <0.0001% |
| WIGGINS MARK C | Chief Business Officer | 13700 0.044% | $1.45 | 3 | 0 | <0.0001% |
| PELLETIER SAUNDRA L | director | 12045 0.0387% | $1.45 | 3 | 0 | +132.9% |
| LARUE WILLIAM R | director | 7763 0.0249% | $1.45 | 1 | 2 | <0.0001% |
| SHAZER RONALD L | Chief Medical Officer | 335 0.0011% | $1.45 | 0 | 1 | |
| LOGAN H CASEY | Chief Business Officer | 0 0% | $1.45 | 0 | 1 |
Institutional Investor Ownership
| LINSCO PRIVATE LEDGER CORP | $193.69M | 16.82 | 450,650 | New | +$193.69M | 0.11 | |
| Acadian Asset Management | $176,000.00 | 15.45 | 413,909 | 0% | +$0 | <0.01 | |
| Squarepoint Ops LLC | $167.19M | 14.52 | 388,985 | -5.65% | -$10.01M | 0.64 | |
| Renaissance Technologies | $129,000.00 | 11.21 | 300,238 | +206.25% | +$86,877.08 | <0.0001 | |
| Geode Capital Management | $123.23M | 10.7 | 286,709 | +37.32% | +$33.49M | 0.01 | |
| The Vanguard Group | $112.94M | 9.81 | 262,772 | 0% | +$0 | <0.01 | |
| BlackRock | $111.78M | 9.71 | 260,084 | -0.45% | -$506,303.93 | <0.01 | |
| Jane Street Capital | $78.36M | 6.81 | 182,307 | New | +$78.36M | 0.08 | |
| UBS | $39.27M | 3.41 | 91,333 | New | +$39.27M | 0.01 | |
| Johnson & Johnson | $36.1M | 3.14 | 84,003 | 0% | +$0 | 0.82 | |
| Susquehanna International Group | $33.47M | 2.91 | 77,868 | New | +$33.47M | 0.04 | |
| State Street | $32.3M | 2.81 | 75,154 | 0% | +$0 | <0.01 | |
| Millennium Management LLC | $32.09M | 2.79 | 74,658 | -61.01% | -$50.2M | 0.02 | |
| Ci Private Wealth Llc | $24.7M | 2.15 | 57,455 | 0% | +$0 | 0.01 | |
| Hrt Financial Llc | $23,000.00 | 2.03 | 54,364 | New | +$23,000.00 | <0.0001 | |
| Two Sigma | $14.97M | 1.3 | 34,822 | New | +$14.97M | 0.03 | |
| Xtx Topco Ltd | $12.02M | 1.04 | 27,965 | New | +$12.02M | 0.66 | |
| ETF Portfolio Partners | $10.59M | 0.92 | 24,641 | New | +$10.59M | 3.25 | |
| Northern Trust | $9.32M | 0.81 | 21,691 | 0% | +$0 | <0.01 | |
| HoyleCohen Wealth Management | $5.59M | 0.49 | 13,000 | 0% | +$0 | 0.43 | |
| Jump Financial Llc | $4.51M | 0.39 | 10,500 | New | +$4.51M | 0.04 | |
| BNY Mellon | $4.41M | 0.38 | 10,259 | 0% | +$0 | <0.01 | |
| Mercer Global Advisors Inc Adv | $4,000.00 | 0.37 | 10,000 | New | +$4,000.00 | <0.0001 | |
| Tower Research Capital | $3.26M | 0.28 | 7,579 | -26.88% | -$1.2M | 0.03 | |
| Game Plan Financial Advisors Llc | $430,000.00 | 0.04 | 1,000 | 0% | +$0 | 0.26 | |
| Truvestments Capital Llc | $137,000.00 | 0.01 | 318 | 0% | +$0 | 0.05 | |
| Wells Fargo | $89,000.00 | 0.01 | 207 | +1.47% | +$1,289.86 | <0.0001 | |
| Royal Bank of Canada | $0 | 0.01 | 150 | -40.24% | -$0 | <0.0001 |